Pubblicazioni

2019

• Fusaro M, Gallieni M, Aghi A, Rizzo MA, Iervasi G, Nickolas TL, Fabris F, Mereu MC, Giannini S, Sella S, Giusti A, Pitino A, D'Arrigo G, Rossini M, Gatti D, Ravera M, Di Lullo L, Bellasi A, Brunori G, Piccoli A, Tripepi G, Plebani M. Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus. J Nephrol. 2019 Aug;32(4):635-643.

2018

• Frediani B, Giusti A, Bianchi G, Dalle Carbonare L, Malavolta N, Cantarini L,  Saviola G, Molfetta L. Clodronate in the management of different musculoskeletal  conditions. Minerva Med. 2018 Aug;109(4):300-325.

2017

• Baldan A, Giusti A, Bosi C, Malaventura C, Forni G, Borgna-Pignatti C. Pseudoxanthoma Elasticum-Like in β-Thalassemia Major, a matter of α-Klotho and Parathyroid Hormone? Hemoglobin. 2017 Dec 11:1-6. [Epub ahead of print]

• Fusaro M, Aghi A, Mereu MC, Giusti A. [Fragility fracture in the Chronic Kidney Disease (CKD)]. G Ital Nefrol. 2017 Dec 5;34(Nov-Dec). pii: 2017-vol6. Review. Italian. PubMed PMID: 29207223.
• Giusti A, Fusaro M. [The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures]. G Ital Nefrol. 2017 Dec 5;34(Nov-Dec). pii: 2017-vol6. Review. Italian. PubMed PMID: 29207226
• Iolascon G, Gimigliano R, Bianco M, De Sire A, Moretti A, Giusti A, Malavolta  N, Migliaccio S, Migliore A, Napoli N, Piscitelli P, Resmini G, Tarantino U, Gimigliano F. Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review. J Nutr Health Aging. 2017;21(5):527-538.
• Monacelli F, Sartini M, Bassoli V, Becchetti D, Biagini AL, Nencioni A, Cea M, Borghi R, Torre F, Odetti P. Validation of the Photography Method for Nutritional Intake Assessment in Hospitalized Elderly Subjects. J Nutr Health Aging. 2017;21(6):614-621.
• Poli S, Cella A, Puntoni M, Musacchio C, Pomata M, Torriglia D, Vello N, Molinari B, Pandolfini V, Torrigiani C, Pilotto A. Frailty is associated with socioeconomic and lifestyle factors in community-dwelling older subjects. Aging Clin Exp Res. 2017 Aug;29(4):721-728.

2016

• Giusti A, Pinto V, Forni GL, Pilotto A. Management ofbeta-thalassemia-associated osteoporosis. Ann N Y Acad Sci. 2016 Apr 6.
• Pedrazzoni M, Giusti A, Girasole G, Abbate B, Verzicco I, Cervellin G. Atypical femoral fractures in Italy: a retrospective analysis in a large urban emergency department during a 7-year period (2007-2013). J Bone Miner Metab. 2016 Nov 9.
• Poli S, Cella A, Puntoni M, Musacchio C, Pomata M, Torriglia D, Vello N, Molinari B, Pandolfini V, Torrigiani C, Pilotto A. Frailty is associated with socioeconomic and lifestyle factors in community-dwelling older subjects. Aging Clin Exp Res. 2016 Aug 27
• Rossini M, Adami S, Bertoldo F, Diacinti D, Gatti D, Giannini S, Giusti A, Malavolta N, Minisola S, Osella G, Pedrazzoni M, Sinigaglia L, Viapiana O, Isaia GC. Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo. 2016 Jun 23;68(1):1-39.

2015

• Baldan A, Giusti A, Bosi C, Malaventura C, Musso M, Forni GL, Volpato S, Zuliani G, Borgna-Pignatti C. Klotho, a new marker for osteoporosis and muscle strength in β-thalassemia major. Blood Cells Mol Dis. 2015 Dec;55(4):396-401.
• Favero M, Giusti A, Geusens P, Goldring SR, Lems W, Schett G, Bianchi G. OsteoRheumatology: a new discipline? RMD Open. 2015 Aug 15;1(Suppl 1):e000083. eCollection 2015.
• Giusti A, Bianchi G. Treatment of complex regional pain syndrome type I with bisphosphonates. RMD Open. 2015 Aug 15;1(Suppl 1):e000056. eCollection 2015. Review.
• Giusti A, Bianchi G. Treatment of primary osteoporosis in men. Clin Interv Aging. 2014 Dec 30;10:105-15. eCollection 2015.

2014

• Giusti A. Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials. J Bone Miner Metab. 2014 Nov;32(6):606-15.
• Giusti A, Bianchi G. Male osteoporosis. Reumatismo. 2014 Jul 28;66(2):136-43.
• Giusti A, De Vincentiis A, Fratoni F, Giovale M, Bianchi G. Effect of Repeated Application of Low-Intensity Pulsed Electromagnetic Fields (PEMF) on Gait Speed in Older Adults with a History of Falls. J Am Geriatr Soc. 2014 Jun;62(6):1185-6.
• Pioli G, Barone A, Mussi C, Tafaro L, Bellelli G, Falaschi P, Trabucchi M, Paolisso G; On behalf of GIOG. The management of hip fracture in the older population. Joint position statement by Gruppo Italiano Ortogeriatria (GIOG). Aging Clin Exp Res. 2014 Feb 25.

2013

• Ameri P, Giusti A, Boschetti M, Murialdo G, Minuto F, Ferone D. Interactions between vitamin D and IGF-I: from physiology to clinical practice. Eur J Endocrinol. 2013 Oct 21;169(6):767-72.
• Giusti A, Giovale M, Ponte M, Fratoni F, Tortorolo U, De Vincentiis A, Bianchi G. Short-term effect of low-intensity, pulsed, electromagnetic fields on gait characteristics in older adults with low bone mineral density: A pilot randomized-controlled trial. Geriatr Gerontol Int. 2013 Apr;13(2):393-7.
• Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS); Italian Society of Rheumatology (SIR), Varenna M, Bertoldo F, Di Monaco M, Giusti A, Martini G, Rossini M. Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature. Reumatismo. 2013 Oct 31;65(4):143-66.
• Liem IS, Kammerlander C, Suhm N, Blauth M, Roth T, Gosch M, Hoang-Kim A, Mendelson D, Zuckerman J, Leung F, Burton J, Moran C, Parker M, Giusti A, Pioli G, Goldhahn J, Kates SL; Investigation performed with the assistance of the AOTrauma Network. Identifying a standard set of outcome parameters for the evaluation of orthogeriatric co-management for hip fractures. Injury. 2013 Nov;44(11):1403-12.

2012

• Forni GL, Perrotta S, Giusti A, Quarta G, Pitrolo L, Cappellini MD, D'Ascola DG, Borgna Pignatti C, Rigano P, Filosa A, Iolascon G, Nobili B, Baldini M, Rosa  A, Pinto V, Palummeri E. Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study. Br J Haematol. 2012 Jul;158(2):274-82.
• Pellicciotti F, Giusti A, Gelli MC, Foderaro S, Ferrari A, Pioli G. Challenges in the differential diagnosis of hypercalcemia: A case of hypercalcemia with normal PTH level. World J Clin Oncol. 2012 Jan 10;3(1):7-11.

2011

• Adami S, Romagnoli E, Carnevale V, Scillitani A, Giusti A, Rossini M, Gatti D, Nuti R, Minisola S. Guidelines on prevention and treatment of vitamin D deficiency. Reumatismo. 2011 Nov 9;63(3):129-47.
• Cauley JA, Black D, Boonen S, Cummings SR, Mesenbrink P, Palermo L, Man Z, Hadji P, Reid IR; HORIZON Pivotal Fracture Group. Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial. J Bone Miner Res. 2011 May;26(5):984-92. (Barone A.)
• Diacinti D, Pisani D, Del Fiacco R, Francucci CM, Fiore CE, Frediani B, Barone A, Bartalena T, Cattaruzza MS, Guglielmi G, Diacinti D, Romagnoli E, Minisola S. Vertebral morphometry by X-ray absorptiometry: Which reference data for vertebral heights? Bone. 2011 Jun 6.
• Giusti A, Barone A, Razzano M, Pizzonia M, Pioli G. Optimal setting and care organization in the management of older adults with hip fracture. Eur J Phys Rehabil Med. 2011 Jun;47(2):281-96.
• Pedrazzoni M, Girasole G, Giusti A, Barone A, Pioli G, Passeri G, Palummeri E,Bianchi G. Assessment of the 10-Year Risk of Fracture in Italian Postmenopausal Women Using FRAX®: a North Italian Multicenter Study. J Endocrinol Invest.  2011 Jul 12.
• Pedrazzoni M, Giusti A, Pioli G. Uses and misuses of statistics: the case of strontium ranelate and the number needed to treat. J Endocrinol Invest. 2011 Sep;34(8):572-5.

2010

• Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM; HORIZON Pivotal Fracture Trial (Barone A). Effect of once-yearly zoledronic acid on the  spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial. Osteoporos Int. 2010 Jul;21(7):1277-85.
• Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M, Pedrazzoni M, Palummeri E, Bianchi G. Heterogeneity in Serum 25-Hydroxy-Vitamin D Response to Cholecalciferol in Elderly Women with Secondary Hyperparathyroidism and Vitamin D Deficiency. J Am Geriatr Soc. 2010 Jul 14.

2009

• Barone A, Giusti A, Pizzonia M, Razzano M, Oliveri M, Palummeri E, Pioli G.
  Factors associated with an immediate weight-bearing and early ambulation program for older adults after hip fracture repair. Arch Phys Med Rehabil. 2009 Sep;90(9):1495-8.
• Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K, Cummings SR, Delmas PD, Palermo L, Mesenbrink P, Cauley JA; HORIZON Pivotal Fracture Trial.
  Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab. 2009 Sep;94(9):3215-25.
• Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Bianchi G.
  Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Nephrol Dial Transplant. 2009 May;24(5):1472-7.
• Giusti A, Barone A, Razzano M, Oliveri M, Pizzonia M, Palummeri E, Pioli G.
  Persistence with calcium and vitamin D in elderly patients after hip fracture. J Bone Miner Metab. 2009;27(1):95-100.

2008

• Barone A, Giusti A, Pioli G, Girasole G, Pizzonia M, Razzano M, Palummeri E, Bianchi G. Was it inappropriate to give osteoporosis patients calcitriol instead of vitamin D? J Am Geriatr Soc 2008;56:576-577.
• Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Pioli G. Predictors of hospital readmission in a cohort of 236 elderly discharged after surgical repair of hip fracture: one-year follow-up. Aging Clin Exp Res. 2008 Jun;20(3):253-9
• Pioli G, Giusti A, Barone A. Orthogeriatric care for the elderly with hip fractures: where are we? Aging Clin Exp Res. 2008 Apr;20(2):113-22. Review

2007

• Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. J Am Geriatr Soc 2007;55:752-757.
• Giusti A, Barone A, Pioli G. Rehabilitation after hip fracture in patients with dementia. J Am Geriatr Soc 2007;55:1309-1310.
• Barone A, Giusti A, Pioli G. Hypovitaminosis D and secondary hyperparathyroidism in the elderly: risk factors for hip fracture or markers of frailty? Osteoporos Int 2007;18:1561-1562.

2006

• Barone A, Giusti A, Pizzonia M, Razzano M, Palummeri E, Pioli G. A comprehensive geriatric intervention reduces short- and long-term mortality in older people with hip fracture. J Am Geriatr Soc 2006;54:711-712.
• Giusti A, Barone A, Oliveri M, Pizzonia M, Razzano M, Palummeri E, Pioli G. An analisys of the feasibility of home rehabilitation among elderly people with proximal femoral fractures. Arch Phys Med Rehabil 2006;87:826-831.
• Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, Pioli G. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest 2006;29:809-813.
• Pioli G, Barone A, Giusti A, Oliveri M, Pizzonia M, Razzano M, Palummeri E. Predictors of mortality after hip fracture: results from 1 year follow up. Aging Clin Exp Res 2006;18:381-387.